Bsx nyse.

Boston Scientific Revenue. Boston Scientific had revenue of $13.40B in the twelve months ending June 30, 2023, with 8.69% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $3.60B with 10.94% year-over-year growth. In the year 2022, Boston Scientific had annual revenue of $12.68B with 6.68% growth.Web

Bsx nyse. Things To Know About Bsx nyse.

Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio. MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic …1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain …

9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc.(LSE: BTG) pursuant to the previously ...

MARLBOROUGH, Mass., Oct. 6, 2021 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and ...

MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ...MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and …WebAnalysis of the Boston Scientific Corp. (NYSE:BSX) seasonal charts above shows that a Buy Date of October 27 and a Sell Date of January 21 has resulted in a ...Dec 4, 2023 · Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the medical equipment provider's stock, valued at ...

BSX Boston Scientific Corporation MORNING UPDATE: Man Securities Issues Alerts for AMD, BSX, AAPL, QLGC, And RMBSWeb

BSX NYSE. BSX NYSE. BSX NYSE. Mercado fechado Mercado fechado. Sem negociações. Veja nos super gráficos. Visão geral . Notícias Ideias Finanças Sinais técnicos Previsão . Gráfico de BSX. Hoje −0.31% 5 dias 3.46% 1 mês 8.11% 6 meses 0.60% Year to date 15.86% 1 ano 26.41% 5 anos 46.05% Todos 1167.06%.

Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index. The company reported mixed Q4 results last month, with revenue falling ...MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac …During the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.16 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $50.71, reflecting an intraday gain of 0.50% or $0.25.MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.On October 27, investment advisory Canaccord maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) stock and lowered the price target to $60 from $64, appreciating the strong ...Nov 29, 2023 · Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]

MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.According to the latest 13F filings, Millennium Management owned 11 million shares of Boston Scientific Corporation (NYSE:BSX) at the end of September 2023 worth $561 million, representing 0.28% ...Boston Scientific's CEO is Mike Mahoney, appointed in Oct 2011, has a tenure of 12.08 years. total yearly compensation is $16.94M, comprised of 8.2% salary and 91.8% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $90.49M. The average tenure of the management team and the board of directors is ...Feb 1, 2023 · Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ... Boston Scientific Corporation (NYSE:BSX), Medtronic plc (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are met by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in our list of biggest medical devices stocks.Web08 Mar, 2022, 16:30 ET. MARLBOROUGH, Mass., March 8, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) (the "Company") today announced that American Medical Systems Europe B.V., its ...

BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023. MARLBOROUGH, Mass. , Oct. 26, 2023 /PRNewswire/ -- Boston Scientific …Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Apr 27, 2022 · 27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ... On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]Market Activity. Funds + ETFs. After-Hours Quotes. Investing Lists. News + Insights. P/E & PEG Ratios. ©2021, EDGAR®Online, a division of Donnelley Financial …

Feb 1, 2023 · Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...

APP Sindical Baixe nosso aplicativo! Emissão de Boletos Contribua com o sindicato e fortaleça a categoria. CCTS e ACTs Baixe todas as nossas convenções coletivas e …

Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If that ...Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.Their BSX share price targets range from $55.00 to $66.00. On average, they anticipate the company's share price to reach $60.55 in the next year. This …Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates.Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share. Boston Scientific has not formally confirmed its next …Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX has been showing a green trend so far today with a performance of 0.09% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 53.10 on Friday, 11/03/23 increased the stock’s daily price by 0.98%.Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Feb 1, 2023 · Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...

Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.BSX Boston Scientific Corporation MORNING UPDATE: Man Securities Issues Alerts for AMD, BSX, AAPL, QLGC, And RMBSWebAccording to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $60.55 with a high price target of $66.00 and a low price target of $55.00 ...Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ... Instagram:https://instagram. dividend oil stockscan you make money on startengineex dividend dates upcomingmagazine issues Boston Scientific Insider Sold Shares Worth $632,269, According to a Recent SEC Filing. Nov. 16. MT. Transcript : Boston Scientific Corporation Presents at The Stifel 2023 Annual Healthcare Conference, Nov-14-2023 08:00 AM. Nov. 14.This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive …Web doordash weedbill com news May 1, 2023 · Boston Scientific Corporation (NYSE:BSX) is an established medical device manufacturer, with a strong global presence across many different medical specialties, yet has been following a growth ... BSX 30-Year Financial Data. The intrinsic value of BSX. Boston Scientific is a leading producer of less invasive medical devices that are inserted into the human body through small openings or ... dividend history mo Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, has recently ventured into chronic pain management.The company’s strategic acquisition of ...